Stocktoria
ENDRA Life Sciences Inc. NDRA
ENDRA Life Sciences Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | 100.0% | 50.9% | 54.3% |
| Operating margin | — | — | — | — | — | — | — | -146080.5% | -1315.6% | -347.5% |
| Net margin | — | — | — | — | — | — | — | -158669.6% | -1529.2% | -538.3% |
| FCF margin | — | — | — | — | — | — | — | -126376.4% | -941.0% | — |
| Return on assets | -182.4% | -258.5% | -148.9% | -142.1% | -87.2% | -133.8% | -185.4% | -135.6% | -87.8% | -565.5% |
| Return on equity | -310.9% | -449.5% | -177.8% | -182.9% | -104.1% | -163.6% | -279.5% | -156.8% | -101.9% | 310.5% |
| Debt / equity | — | 0.00× | 0.00× | 0.00× | 0.05× | — | — | — | — | — |
| Current ratio | 1.29 | 5.67 | 3.36 | 3.16 | 7.83 | 8.32 | 3.15 | 7.13 | 6.93 | 0.14 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.